Evidence map›Paper›PMID 29301827›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma.

Lotfi Abou-Elkacem, Huaijun Wang, Sayan M Chowdhury, Richard H Kimura, Sunitha V Bachawal, Sanjiv S Gambhir, Lu Tian, Jürgen K Willmann

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Molecular Ultrasound Imaging.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Molecular Ultrasound Imaging.Nanomaterials (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lotfi Abou-ElkacemDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford, California. kacem@stanford.edu.
Huaijun WangDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford, California.
Sayan M ChowdhuryDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford, California.
Richard H KimuraDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford, California.
Sunitha V BachawalDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford, California.
Sanjiv S GambhirDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford, California.
Lu TianDepartment of Health, Research and Policy, Stanford University, Stanford, California.
Jürgen K WillmannDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford, California.
Stanford Medicine · USStanford Health Care · US

Funding

Nano Characterization and Nano Fabrication CoreU54CA199075 · NCI · STANFORD UNIVERSITY · PI GAMBHIR, SANJIV S · 2015 to 2019
$9.6M
Molecular Imaging Methods for the Detection of Pancreatic Ductal AdenocarcinomaU01CA210020 · NCI · STANFORD UNIVERSITY · PI IAGARU, ANDREI, PARK, WALTER GWANG-UP · 2017 to 2021
$4.1M
Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent DevelopmentR44CA203090 · NCI · NUVOX PHARMA, LLC · PI GAMBHIR, SANJIV S, UNGER, EVAN CHARLES · 2018 to 2019
$2.0M
Molecular Ultrasound for Early Breast Cancer DetectionR01CA155289 · NCI · STANFORD UNIVERSITY · PI WILLMANN, JUERGEN KARL · 2011 to 2015
$1.6M
High Sensitivity Molecular Ultrasound Imaging in Pancreatic CancerR21EB022770 · NIBIB · STANFORD UNIVERSITY · PI DAHL, JEREMY · 2016 to 2017
$435k
Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent DevelopmentR41CA203090 · NCI · NUVOX PHARMA, LLC · PI UNGER, EVAN CHARLES, WILLMANN, JUERGEN KARL · 2016 to 2016
$298k
NCI NIH HHS R01 CA155289NCI NIH HHS R41 CA203090NCI NIH HHS R44 CA203090NCI NIH HHS U01 CA210020NCI NIH HHS U54 CA199075NIBIB NIH HHS R21 EB022770
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCarcinoma, Pancreatic DuctalContrast MediaDisease Models, AnimalFemaleHumansMiceMice, NudeMicrobubblesMolecular ImagingPancreasPancreatic NeoplasmsThy-1 AntigensUltrasonographyContrast MediaThy-1 Antigens

Identifiers

PMID29301827
PMCPMC5884723
OpenAlexW2782138710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.